6590 A phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer

✍ Scribed by Nakachi, K.; Okusaka, T.O.; Funakoshi, A.F.; Ioka, T.I.; Yamao, K.Y.; Ohkawa, S.O.; Boku, N.B.; Komatsu, Y.K.; Nakamori, S.N.; Furuse, J.F.

• Book ID: 122789557
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 49 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71311-4